Showing 2,501 - 2,520 results of 3,491 for search '"Stem Cell"', query time: 0.07s Refine Results
  1. 2501
  2. 2502
  3. 2503

    AIDS-Related Non-Hodgkin's Lymphoma in the Era of Highly Active Antiretroviral Therapy by Prakash Vishnu, David M. Aboulafia

    Published 2012-01-01
    “…Clinical trials investigating the role of allogeneic hematopoietic stem cell transplant in ARL are currently underway.…”
    Get full text
    Article
  4. 2504

    Cellular Plasticity in Prostate Cancer Bone Metastasis by Dima Y. Jadaan, Mutaz M. Jadaan, John P. McCabe

    Published 2015-01-01
    “…An electronic search was performed using PubMed for studies that have examined the differential expression of epithelial, mesenchymal, and stem cell markers in human PC bone metastasis tissues. …”
    Get full text
    Article
  5. 2505

    Effect of Age and Diabetes on the Response of Mesenchymal Progenitor Cells to Fibrin Matrices by A. Stolzing, H. Colley, A. Scutt

    Published 2011-01-01
    “…Mesenchymal stem cells are showing increasing promise in applications such as tissue engineering and cell therapy. …”
    Get full text
    Article
  6. 2506
  7. 2507
  8. 2508
  9. 2509
  10. 2510

    Nanosensor-based imaging of realtime dopamine release in neurons derived from iPSCs of patients with Parkinson's disease by Nayeon Lee, Dakyeon Lee, Jae Hyeok Lee, Bo Seok Lee, Sungjee Kim, Jae Ho Kim, Sanghwa Jeong

    Published 2025-04-01
    “…In this study, we applied NIRCat to elucidate DA release in human induced pluripotent stem cells (hiPSCs)-derived dopaminergic neurons from both healthy control and PD patient carrying GBA1 mutations. …”
    Get full text
    Article
  11. 2511

    Apoptotic Vesicles Attenuate Acute Lung Injury via CD73-Mediated Inhibition of Platelet Activation and NETosis by Tan L, Zhang C, Kou X, Zhao L, Wu D, Li J, Yu C, Xu T, Gao L, Mao X, Zhao C

    Published 2025-01-01
    “…To date, no pharmacological treatment has proven effective for ARDS. Mesenchymal stem cell-derived apoptotic vesicles (apoVs) were recently found to have excellent therapeutic potential for inflammatory diseases. …”
    Get full text
    Article
  12. 2512
  13. 2513
  14. 2514

    Characterization of Ex Vivo Expanded Oral Mucosal Epithelium Cells on Acellular Porcine Corneal Stroma for Ocular Surface Reconstruction by Jia-Song Wang, Hua-Tao Xie, Ming-Chang Zhang

    Published 2017-01-01
    “…Characterization showed that these sheets retain the morphologic and phenotypic characteristics of OMECs within differentiated cells and stem cells. The optimal transplantable sheets can prove to be particularly beneficial to both bilateral limbal stem cell deficiency and deep corneal lesions.…”
    Get full text
    Article
  15. 2515

    Multimodal Imaging of Neural Progenitor Cell Fate in Rodents by Yannic Waerzeggers, Markus Klein, Hrvoje Miletic, Uwe Himmelreich, Hongfeng Li, Parisa Monfared, Ulrich Herrlinger, Mathias Hoehn, Heinrich Hubert Coenen, Michael Weller, Alexandra Winkeler, Andreas Hans Jacobs

    Published 2008-03-01
    “…For clinical application of stem cell–based therapies, noninvasive detection of applied stem cells is of high importance. …”
    Get full text
    Article
  16. 2516

    Diagnosis and Management of Atypical Chronic Myeloid Leukemia with a t(2;13)(q33;q12) Translocation by John S. Wang, Omar Elghawy, Brett R. Kurpiel, Michael G. Douvas

    Published 2022-01-01
    “…Allogeneic hematopoietic stem cell transplant is likely the preferred treatment, but this can be limited by patient psychosocial support, age, concomitant medical conditions, and availability of an appropriate donor. …”
    Get full text
    Article
  17. 2517

    Germ Cell Proteins in Melanoma: Prognosis, Diagnosis, Treatment, and Theories on Expression by Ashley M. Rosa, Nitika Dabas, Diana M. Byrnes, Mark S. Eller, James M. Grichnik

    Published 2012-01-01
    “…There is an ever increasing recognition that within tumors there is a subpopulation of cells with stem-cell-like characteristics that play a role in driving tumorgenesis. …”
    Get full text
    Article
  18. 2518

    Brentuximab Vedotin Treatment for Primary Refractory Hodgkin Lymphoma by Hung-Bo Wu, Shyh-An Yeh, Huei-Yung Chen

    Published 2013-01-01
    “…With intensive salvage chemotherapy and autologous stem cell transplantation, the long-term remission rate for these patients was only 30%, but more selective treatments with higher therapeutic index are needed. …”
    Get full text
    Article
  19. 2519

    Frailty-adjusted therapy in Transplant Non-Eligible patients with newly diagnosed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III... by Roger Owen, John Jones, David Meads, David A Cairns, Christopher Parrish, Gordon Cook, Neil Rabin, Matthew Jenner, Martin Kaiser, Kevin Boyd, Graham Jackson, Catherine Olivier, Amy Beth Coulson, Kara-Louise Royle, Charlotte Pawlyn, Anna Hockaday, Jennifer Bird, Stella Bowcock, Ruth de Tute, Hayley Gardner, Bryony Dawkins, Rowena Henderson, Phillip Best, Bhuvan Kishore, Mark Drayson

    Published 2022-06-01
    “…However, this is less apparent in older, less fit patients, who are ineligible for stem cell transplant. Research is required in this patient group, taking into account frailty and aiming to improve: treatment tolerability, clinical outcomes and quality of life.Methods and analysis Frailty-adjusted therapy in Transplant Non-Eligible patients with newly diagnosed Multiple Myeloma is a national, phase III, multicentre, randomised controlled trial comparing standard (reactive) and frailty-adjusted (adaptive) induction therapy delivery with ixazomib, lenalidomide and dexamethasone (IRD), and to compare maintenance lenalidomide to lenalidomide+ixazomib, in patients with newly diagnosed multiple myeloma not suitable for stem cell transplant. …”
    Get full text
    Article
  20. 2520